Literature DB >> 12861339

Dynamic exercise attenuates spontaneous baroreceptor reflex sensitivity in conscious rats.

Hidefumi Waki1, Sergey Kasparov, Kiyoaki Katahira, Tsuyoshi Shimizu, David Murphy, Julian F R Paton.   

Abstract

In humans, it has been reported that dynamic exercise attenuates spontaneous baroreceptor reflex sensitivity (sBRS), which is an index of the gain of the baroreceptor-cardiac reflex. We demonstrated previously that endogenously produced NO from endothelial nitric oxide synthase (eNOS) within the nucleus tractus solitarii (NTS), the central terminal site of baroreceptor afferents, depressed sBRS. In this study, we investigated whether eNOS activity within the NTS plays any role in down-modulating the sBRS during dynamic exercise. In conscious Wistar rats arterial pressure and heart rate (HR) were monitored continuously and chronically using radiotelemetry before and during wheel cage running at 6 m min(-1) for 10 min. sBRS was determined by a time-series method. During dynamic exercise systolic blood pressure (SBP) and HR were significantly increased (SBP: 138 +/- 2 vs. 125 +/- 2 mmHg, P < 0.001; HR: 447 +/- 6 vs. 362 +/- 8 beats min(-1), P < 0.001) while sBRS was significantly decreased (0.53 +/- 0.03 vs. 1.08 +/- 0.08 ms mmHg(-1), P < 0.001). In sino-aortic denervated rats the change in SBP in response to dynamic exercise was significantly larger than that in baroreceptor-intact rats (denervated: 21.6 +/- 2.5 mmHg; intact: 12.0 +/- 2.8 mmHg, P < 0.05). In contrast, denervation made no difference to the change in HR. Although disabling eNOS activity in the NTS by adenoviral-directed expression of a dominant negative mutant form of eNOS increased resting sBRS (1.48 +/- 0.20 vs. 1.09 +/- 0.15 ms mmHg(-1), P < 0.05), the absolute level reached during dynamic exercise was identical to control. These results demonstrate that during dynamic exercise (i) the sBRS decreases around the operating point of the baroreceptor-cardiac reflex function curve in normotensive rats, (ii) the baroreceptor reflex operates to limit the rise in arterial pressure, and (iii) the attenuation of sBRS is not mediated by changes in eNOS activity within the NTS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861339     DOI: 10.1113/eph8802545

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  7 in total

1.  Progressive muscle metaboreflex activation gradually decreases spontaneous heart rate baroreflex sensitivity during dynamic exercise.

Authors:  Javier A Sala-Mercado; Masashi Ichinose; Matthew Coutsos; Zhenhua Li; Dominic Fano; Tomoko Ichinose; Elizabeth J Dawe; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-04       Impact factor: 4.733

2.  Effect of age on high-fat diet-induced hypertension.

Authors:  Benedek Erdos; Nataliya Kirichenko; Melissa Whidden; Bilgen Basgut; Mary Woods; Idan Cudykier; Rabih Tawil; Philip J Scarpace; Nihal Tumer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-06       Impact factor: 4.733

3.  Dynamic cardiac output regulation at rest, during exercise, and muscle metaboreflex activation: impact of congestive heart failure.

Authors:  Masashi Ichinose; Javier A Sala-Mercado; Matthew Coutsos; Zhenhua Li; Tomoko K Ichinose; Elizabeth Dawe; Dominic Fano; Donal S O'Leary
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-01       Impact factor: 3.619

4.  Cerebral Aβ40 and systemic hypertension.

Authors:  Hannah M Tayler; Jennifer C Palmer; Taya L Thomas; Patrick G Kehoe; Julian Fr Paton; Seth Love
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-07       Impact factor: 6.200

5.  Physical exercise performance in temperate and warm environments is decreased by an impaired arterial baroreflex.

Authors:  Washington Pires; Samuel P Wanner; Milene R M Lima; Ivana A T Fonseca; Ubirajara Fumega; Andrea S Haibara; Cândido C Coimbra; Nilo R V Lima
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

6.  Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome.

Authors:  Hiroaki Kusaka; Nobutaka Koibuchi; Yu Hasegawa; Hisao Ogawa; Shokei Kim-Mitsuyama
Journal:  Cardiovasc Diabetol       Date:  2016-11-11       Impact factor: 9.951

7.  Zibotentan, an Endothelin A Receptor Antagonist, Prevents Amyloid-β-Induced Hypertension and Maintains Cerebral Perfusion.

Authors:  Jennifer C Palmer; Hannah M Tayler; Laurence Dyer; Patrick G Kehoe; Julian F R Paton; Seth Love
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.